Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

View:
Post by WarrantOfficer on Jun 26, 2024 2:46pm

424K @ .08

The bid of 424K @.08 went thru. Let's see if .08 will hold.
Comment by oldtrouf on Jun 26, 2024 3:20pm
Not a chance.  This will be sitting at 3 or 4 cents within 6 weeks.  And that is IF they do not go bankrupt.  As we all know another PP is out of the question.  The last PP was a disaster.  After some research I am thinking Raincage is also a very small company with little or no sales.  Similar to TMG.  There is really nothing here.  Sales are years away if ...more  
Comment by biggdogg on Jun 27, 2024 11:28am
LOL, every time Oldtrouf speaks up, good things happen. If you look closely at the quarterly reports, Management is not taking much salary, and may be off salary. Mars was hosted by J&J and Bayer, two big pharma companies, and dozens of capital firms. The Voy story is a complex one, but with War 100% coming down the rail line, this company may end up with all sorts of financing, just to ensure ...more  
Comment by postie1 on Jun 27, 2024 4:11pm
And that is why I think a takeover attempt will be sooner rather than later. The licences anf formulas alone plus the deposit have to be worth more than .08 a share. These products plus the Iodine can be a door opener for mid size companies trying to sell their products. $1 + a share would be peanuts for a 20 billion+ company with cash flow. Really right now there is major upside to VM to any ...more  
Comment by WarrantOfficer on Jun 30, 2024 7:53am
China is preparing for the inevitable..... China issues rare earth regulations to further protect domestic supply (msn.com)
Comment by JrOGInvestor on Jul 07, 2024 5:27pm
and you were so upbeat back in 2021. " I see the target is .39   Got in this am.  Great storey here guys. Long hold for me here.  What ... February 12, 2021 I'm guessing you're out if you've been beating it up for so long. 
Comment by JrOGInvestor on Jul 07, 2024 5:29pm
apparently hit the wrong reply, this was directed at oldtrout, not warrantofficer.
Comment by oldtrouf on Jul 08, 2024 1:17pm
That was 25 news releases ago.  Not one of which ever materialized.  This stock is going to zero.  Another youtube promo of fluff news release  will do nothing.  THe company has no product to sell and no one to sell it to obviously. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1